According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -26,69ย โฌ. In 2022 the company made an earnings per share (EPS) of -2.867ย โฌ an increase over its 2021 EPS that were of -18.945ย โฌ.